Provista is a molecular diagnostics company that develops and commercializes liquid biopsies for the detection and treatment of breast cancer... Read more
Provista is a molecular diagnostics company that develops and commercializes liquid biopsies for the detection and treatment of breast cancer... Read more
News
Oct 17, 2022
Pharmabiz
Provista Diagnostics: Provista Diagnostics seeks US FDA emergency use authorization for PCR MonkeyPox Test
Nov 16, 2021
BioSpace
Provista Diagnostics: Todos Medical's Provista Laboratory to Boost Top Line Through New Atlanta-based Reference Lab Agreement for COVID PCR, cPass Neutralizing Antibody & Respiratory Pathogen Panel Tests
Aug 24, 2021
StreetInsider
Press Release: Provista Diagnostics : Todos Medical's CLIA/CAP Lab Provista Enters Into Reference Lab Agreement with Meadowlands Diagnostics to Provide cPass Neutralizing Antibody Blood Testing for Quantifying and Monitoring Key COVID-1
Aug 03, 2021
Proactive Investors
Provista Diagnostics: Todos Medical makes final payment to close Provista Diagnostics acquisition
Apr 23, 2021
PRWeb
Press Release: Provista Diagnostics : Puerto Rico-based The Strategic Group PR, LLC Has Sold Breast Cancer Detection Firm Provista Diagnostics, Inc.
Apr 22, 2021
Genomeweb
Provista Diagnostics: Todos Medical Acquires Provista Diagnostics for $7.5M
Jan 10, 2020
BioPortfolio
Provista Diagnostics: Todos Medical to buy in vitro diagnostics company Provista Diagnostics
Jun 19, 2019
FinSMEs
Provista Diagnostics: Ascenda BioSciences Acquires Provista Diagnostics
Sep 11, 2018
PR Newswire
Press Release: Provista Diagnostics : Provista Diagnostics Announces Enhanced Breast Cancer Detection Using a Simple Blood Test in New Peer-Reviewed Publication
Nov 15, 2017
Provista Diagnostics Blog
Provista Diagnostics Blog Does Dense Breast Tissue Pose the Same Diagnostic Challenge Using Liquid Biopsy as it Does for Imaging?
Provista Diagnostics Competitors
1
2
3
4
5
6
7
8
9
10